RETRACTION: Knockdown of SRPX2 inhibits the proliferation, migration, and invasion of prostate cancer cells through the PI3K/Akt/mTOR signaling pathway (Retraction of Vol 33, 10.1002/JBT.22237, 2019)

被引：0
|
作者：
Hong, X.
Hong, X.
Zhao, H.
He, C.
机构：
来源：
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY | 2020年 / 34卷 / 12期
关键词：
D O I：
10.1002/jbt.22667
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [31] Knockdown of ARHGAP30 inhibits ovarian cancer cell proliferation, migration, and invasiveness by suppressing the PI3K/AKT/mTOR signaling pathway
    Chu, Xiaoyan
    Lou, Jun
    Yi, Yun
    Zhong, Linlin
    Huang, Ouping
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2023, 67 (02):
  • [32] Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway
    Wu, Chunyu
    Qiu, Shengliang
    Liu, Pei
    Ge, Yuqing
    Gao, Xiufei
    JOURNAL OF ETHNOPHARMACOLOGY, 2018, 211 : 89 - 100
  • [33] SASH1 inhibits proliferation and invasion of thyroid cancer cells through PI3K/Akt signaling pathway
    Sun, Dawei
    Zhou, Rui
    Liu, Huamin
    Sun, Wenhai
    Dong, Anbing
    Zhang, Hongmei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (10): : 12276 - 12283
  • [34] Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K/Akt signaling pathway
    Tang, Shi-lei
    Gao, Yuan-lin
    Hu, Wen-zhong
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 99 : 59 - 64
  • [35] Retraction Note: Downregulation of monocarboxylate transporter 1 inhibits the invasion and migration through suppression of the PI3K/Akt signaling pathway in human nasopharyngeal carcinoma cells
    Pei Zhang
    Jie Ma
    Jiao Gao
    Fang Liu
    Xiaojin Sun
    Fang Fang
    Surong Zhao
    Hao Liu
    Journal of Bioenergetics and Biomembranes, 2024, 56 (5) : 589 - 589
  • [36] TIPE2 Overexpression Suppresses the Proliferation; Migration, and Invasion in Prostate Cancer Cells by Inhibiting PI3K/Akt Signaling Pathway
    Lu, Qiang
    Liu, Zhe
    Li, Zhuo
    Chen, Jia
    Liao, Zhi
    Wu, Wan-rui
    Li, Yuan-wei
    ONCOLOGY RESEARCH, 2016, 24 (05) : 305 - 313
  • [37] RETRACTION: Kuntai capsule attenuates premature ovarian failure through the PI3K/AKT/mTOR pathway (Retraction of Vol 239, art no 111885, 2019)
    Zhang, Han
    Qin, Fenfen
    Liu, Anlong
    Sun, Qinmei
    Wang, Qisheng
    Li, Qian
    Lu, Shengfeng
    Zhang, Dong
    Lu, Zhigang
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 289
  • [38] RETRACTION: Down-Regulation of SREBP via PI3K/AKT/mTOR Pathway Inhibits the Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells (Retraction of Vol 13, Pg 8951, 2020)
    Zhang, B.
    Wu, J.
    Guo, P.
    ONCOTARGETS AND THERAPY, 2022, 15 : 1039 - 1040
  • [39] MiR-198 inhibits proliferation, invasion and migration of ovarian cancer cells by regulating the PI3K/Akt signaling pathway
    Xiao, Huichao
    Zheng, Yafeng
    Chen, Jiming
    Shen, Huaji
    ACTA BIOCHIMICA POLONICA, 2021, 68 (04) : 673 - 677
  • [40] Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway
    Wang, Rong
    Li, Rizhao
    Yang, Huibing
    Chen, Xuejiao
    Wu, Liangliang
    Zheng, Xiaohui
    Jin, Yuepeng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (03)
12345